UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Next generation of adeno-associated virus 2 vectors: Point mutations in tyrosines lead to high-efficiency transduction at lower doses

Proceedings of the National Academy of Sciences - PNAS, 2008-06, Vol.105 (22), p.7827-7832

2008

Volltextzugriff (PDF)

Identification of Amino Acid Residues in the Capsid Proteins of Adeno-Associated Virus Type 2 That Contribute to Heparan Sulfate Proteoglycan Binding

Journal of Virology, 2003-06, Vol.77 (12), p.6995-7006

2003

Volltextzugriff (PDF)

Treatment of human disease by adeno-associated viral gene transfer

Human genetics, 2006-07, Vol.119 (6), p.571-603

2006

Volltextzugriff (PDF)

Biodistribution of adeno-associated virus type 2 with mutations in the capsid that contribute to heparan sulfate proteoglycan binding

Virus research, 2019-12, Vol.274, p.197771-197771, Article 197771

2019

Volltextzugriff (PDF)

Adeno-Associated Virus Type 2 VP2 Capsid Protein Is Nonessential and Can Tolerate Large Peptide Insertions at Its N Terminus

Journal of Virology, 2004-06, Vol.78 (12), p.6595-6609

2004

Volltextzugriff (PDF)

Adenovirus-Facilitated Nuclear Translocation of Adeno-Associated Virus Type 2

Journal of Virology, 2002-11, Vol.76 (22), p.11505-11517

2002

Volltextzugriff (PDF)

Successful Production of Pseudotyped rAAV Vectors Using a Modified Baculovirus Expression System

Molecular therapy, 2005-12, Vol.12 (6), p.1217-1225

2005

Volltextzugriff (PDF)

Custom adeno-associated virus capsids : The next generation of recombinant vectors with novel tropism

Human gene therapy, 2005-04, Vol.16 (4), p.408-416

2005

Volltextzugriff (PDF)

Hematopoietic- and neurologic-expressed sequence 1 (Hn1) depletion in B16.F10 melanoma cells promotes a differentiated phenotype that includes increased melanogenesis and cell cycle arrest

Differentiation (London), 2009-07, Vol.78 (1), p.35-44

2009

Volltextzugriff (PDF)

Role of cellular FKBP52 protein in intracellular trafficking of recombinant adeno-associated virus 2 vectors

Virology (New York, N.Y.), 2006-09, Vol.353 (2), p.283-293

2006

Volltextzugriff (PDF)

Comparison of the EF-1 alpha and the CMV promoter for engineering stable tumor cell lines using recombinant adeno-associated virus

Anticancer research, 2002-11, Vol.22 (6A), p.3325

2002

Volltextzugriff (PDF)

Altering AAV tropism with mosaic viral capsids

Molecular therapy, 2005-06, Vol.11 (6), p.856-865

2005

Volltextzugriff (PDF)

Evaluation of primitive murine hematopoietic stem and progenitor cell transduction in vitro and in vivo by recombinant adeno-associated virus vector serotypes 1 through 5

Human gene therapy, 2006-03, Vol.17 (3), p.321-333

2006

Volltextzugriff (PDF)

Hematopoietic- and Neurologic-Expressed Sequence 1 Expression in the Murine GL261 and High-Grade Human Gliomas

Pathology oncology research, 2009-09, Vol.15 (3), p.437-444, Article 437

2009

Volltextzugriff (PDF)

Recombinant Adeno-associated and Adenoviral Vectors for the Transduction of Pancreatic and Colon Carcinoma

Anticancer research, 2006-01, Vol.26 (1A), p.311-317

2006

Volltextzugriff (PDF)

Self-complementary recombinant adeno-associated viral vectors: packaging capacity and the role of rep proteins in vector purity

Human gene therapy, 2007-02, Vol.18 (2), p.171-182

2007

Volltextzugriff (PDF)

741. Self-Complementary Adeno-Associated Virus Vectors: Packaging Capacity and Purity

Molecular therapy, 2006-05, Vol.13 (S1), p.S286-S286

2006

Volltextzugriff (PDF)

Developing VDEPT for DT-diaphorase (NQO1) using an AAV vector plasmid

International journal of radiation oncology, biology, physics, 1998-11, Vol.42 (4), p.909-912

1998

Volltextzugriff (PDF)

Targeting tumor blood vessels: an adjuvant strategy for radiation therapy

Radiotherapy and Oncology, 2000-10, Vol.57 (1), p.5-12

2000

Volltextzugriff (PDF)

Evaluation of Primitive Murine Hematopoietic Stem and Progenitor Cell Transduction In Vitro and In Vivo by Recombinant Adeno-Associated Virus Vector Serotypes 1 Through 5

Human gene therapy, 2006-03, p.60301061832003

2006

Volltextzugriff (PDF)

Evaluation of Primitive Murine Hematopoietic Stem and Progenitor Cell Transduction In Vitro and In Vivo by Recombinant Adeno-Associated Virus Vector Serotypes 1 Through 5

Human gene therapy, 2006-01, p.60125023345001

2006

Volltextzugriff (PDF)

Efficacy and safety of mavrilimumab in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trial

Annals of the rheumatic diseases, 2022-05, Vol.81 (5), p.653-661

2022

Volltextzugriff (PDF)

A phase 3 randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of sarilumab in patients with giant cell arteritis

Arthritis research & therapy, 2023-10, Vol.25 (1), p.1-199, Article 199

2023

Volltextzugriff (PDF)

Apolipoproteins and the risk of giant cell arteritis-a nested case-control study

Arthritis research & therapy, 2024-01, Vol.26 (1), p.37-7, Article 37

2024

Volltextzugriff (PDF)

High-precision optical-frequency dissemination on branching optical-fiber networks

Optics letters, 2013-08, Vol.38 (15), p.2893

2013

Volltextzugriff (PDF)

1 – 25 von 72

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(65)
Mit Volltextzugriff
(61)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(72)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Next generation of adeno-associated virus 2 vectors: Point mutations in tyrosines lead to high-efficiency transduction at lower doses

Identification of Amino Acid Residues in the Capsid Proteins of Adeno-Associated Virus Type 2 That Contribute to Heparan Sulfate Proteoglycan Binding

Treatment of human disease by adeno-associated viral gene transfer

Biodistribution of adeno-associated virus type 2 with mutations in the capsid that contribute to heparan sulfate proteoglycan binding

Adeno-Associated Virus Type 2 VP2 Capsid Protein Is Nonessential and Can Tolerate Large Peptide Insertions at Its N Terminus

Adenovirus-Facilitated Nuclear Translocation of Adeno-Associated Virus Type 2

Successful Production of Pseudotyped rAAV Vectors Using a Modified Baculovirus Expression System

Custom adeno-associated virus capsids : The next generation of recombinant vectors with novel tropism

Hematopoietic- and neurologic-expressed sequence 1 (Hn1) depletion in B16.F10 melanoma cells promotes a differentiated phenotype that includes increased melanogenesis and cell cycle arrest

Role of cellular FKBP52 protein in intracellular trafficking of recombinant adeno-associated virus 2 vectors

Comparison of the EF-1 alpha and the CMV promoter for engineering stable tumor cell lines using recombinant adeno-associated virus

Altering AAV tropism with mosaic viral capsids

Evaluation of primitive murine hematopoietic stem and progenitor cell transduction in vitro and in vivo by recombinant adeno-associated virus vector serotypes 1 through 5

Hematopoietic- and Neurologic-Expressed Sequence 1 Expression in the Murine GL261 and High-Grade Human Gliomas

Recombinant Adeno-associated and Adenoviral Vectors for the Transduction of Pancreatic and Colon Carcinoma

Self-complementary recombinant adeno-associated viral vectors: packaging capacity and the role of rep proteins in vector purity

741. Self-Complementary Adeno-Associated Virus Vectors: Packaging Capacity and Purity

Developing VDEPT for DT-diaphorase (NQO1) using an AAV vector plasmid

Targeting tumor blood vessels: an adjuvant strategy for radiation therapy

Evaluation of Primitive Murine Hematopoietic Stem and Progenitor Cell Transduction In Vitro and In Vivo by Recombinant Adeno-Associated Virus Vector Serotypes 1 Through 5

Evaluation of Primitive Murine Hematopoietic Stem and Progenitor Cell Transduction In Vitro and In Vivo by Recombinant Adeno-Associated Virus Vector Serotypes 1 Through 5

Efficacy and safety of mavrilimumab in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trial

A phase 3 randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of sarilumab in patients with giant cell arteritis

Apolipoproteins and the risk of giant cell arteritis-a nested case-control study

High-precision optical-frequency dissemination on branching optical-fiber networks

Suchergebnisse filtern